An Open-label Study of Avastin in Combination With Chemotherapy Regimens as Second-line Treatment in Patients With Metastatic Colon or Rectal Cancer.

Trial Profile

An Open-label Study of Avastin in Combination With Chemotherapy Regimens as Second-line Treatment in Patients With Metastatic Colon or Rectal Cancer.

Completed
Phase of Trial: Phase II

Latest Information Update: 30 Sep 2014

At a glance

  • Drugs Bevacizumab (Primary) ; Antineoplastics
  • Indications Colon cancer; Rectal cancer
  • Focus Therapeutic Use
  • Sponsors Roche
  • Most Recent Events

    • 23 May 2013 Actual end date (May 2010) added as reported by ClinicalTrials.gov.
    • 12 Aug 2010 New source identified and integrated (ClinicalTrials.gov: US National Institutes of Health, NCT01181609).
    • 28 May 2010 Status changed from active, no longer recruiting to completed as reported by Roche website.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top